Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Alchemist Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: December 14, 2024, 10:13 am

Market Cap 4.08 Cr.
Current Price 3.01
High / Low /
Stock P/E
Book Value 283
Dividend Yield0.00 %
ROCE9.70 %
ROE%
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Alchemist Ltd

Competitors of Alchemist Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Gujarat Metallic Coal & Coke Ltd 5.94 Cr. 30.0 / 77.60.00 %0.37 %2.00 % 100
Gensol Engineering Ltd 1,107 Cr. 291 1,126/29012.8 1550.00 %14.3 %20.1 % 10.0
Gagan Polycot India Ltd 0.86 Cr. 0.86/ 4.080.00 %81.2 %81.2 % 10.0
Fusion Micro Finance Ltd 1,516 Cr. 150 544/140 2510.00 %14.1 %19.6 % 10.0
Five X Tradecom Ltd 0.99 Cr. 0.48/ 9.350.00 %0.00 %0.00 % 10.0
Industry Average2,413.12N/A131.82N/AN/A20.6161.74N/A

All Competitor Stocks of Alchemist Ltd

Quarterly Result

MetricDec 2012Mar 2013Jun 2013Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020
Sales 3883604099666653111
Expenses 375352398-97388754491373
Operating Profit 1281118-67-2-2-1-1-1-480-372
OPM % 3%2%3%204%-1,116%-25%-43%-16%-14%-52%-3,731%5%-31,800%
Other Income 482001000000124
Interest 2310000000000
Depreciation 3432222222222
Profit before tax 129816-69-3-4-3-2-3-50-1-250
Tax % 11%61%30%-1%1%10%-271%7%8%-54%-20%12%-26%
Net Profit 104516-70-37-3-3-1-40-2-186
EPS in Rs 7.542.703.9511.59-51.46-2.225.48-2.16-1.89-1.08-29.33-1.15-136.88

Last Updated: Unknown

Below is a detailed analysis of the quarterly data for Alchemist Ltd based on the most recent figures (Sep 2020) and their trends compared to the previous period:

  • For Sales, as of Sep 2020, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2020) which recorded 1.00 Cr..
  • For Expenses, as of Sep 2020, the value is ₹373.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Jun 2020) to ₹373.00 Cr., marking an increase of ₹372.00 Cr..
  • For Operating Profit, as of Sep 2020, the value is ₹-372.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Jun 2020) to ₹-372.00 Cr., marking a decrease of 372.00 Cr..
  • For OPM %, as of Sep 2020, the value is -31,800.00%. The value appears to be declining and may need further review. It has decreased from 5.00% (Jun 2020) to -31,800.00%, marking a decrease of 31,805.00%.
  • For Other Income, as of Sep 2020, the value is ₹124.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2020) to ₹124.00 Cr., marking an increase of ₹124.00 Cr..
  • For Interest, as of Sep 2020, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2020) which recorded 0.00 Cr..
  • For Depreciation, as of Sep 2020, the value is ₹2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2020) which recorded 2.00 Cr..
  • For Profit before tax, as of Sep 2020, the value is ₹-250.00 Cr.. The value appears to be declining and may need further review. It has decreased from -1.00 Cr. (Jun 2020) to ₹-250.00 Cr., marking a decrease of 249.00 Cr..
  • For Tax %, as of Sep 2020, the value is -26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 12.00% (Jun 2020) to -26.00%, marking a decrease of 38.00%.
  • For Net Profit, as of Sep 2020, the value is ₹-186.00 Cr.. The value appears to be declining and may need further review. It has decreased from -2.00 Cr. (Jun 2020) to ₹-186.00 Cr., marking a decrease of 184.00 Cr..
  • For EPS in Rs, as of Sep 2020, the value is -136.88. The value appears to be declining and may need further review. It has decreased from ₹-1.15 (Jun 2020) to -136.88, marking a decrease of ₹135.73.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:20 pm

MetricMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales 3863965038861,4571,508350105242727146
Expenses 3553644688521,4171,47537513853368065427
Operating Profit 323235344133-26-33-29-10-53-51-422
OPM % 8%8%7%4%3%2%-7%-32%-121%-36%-199%-354%-7,096%
Other Income 3311216141413-69310124
Interest 8744745522110
Depreciation 8810111215232688776
Profit before tax 192022313828-39-52-108-16-61-58-304
Tax % 28%22%40%23%25%55%-2%3%-1%3%-18%-19%
Net Profit 141613242712-38-53-107-17-50-47-228
EPS in Rs 11.5012.9110.6818.5420.0510.44-26.36-35.67-79.15-12.47-36.61-34.46-168.44
Dividend Payout % 17%16%19%22%7%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2009-20102010-20112011-20122012-20132013-20142014-20152015-20162016-20172017-20182018-20192019-2020
YoY Net Profit Growth (%)14.29%-18.75%84.62%12.50%-55.56%-416.67%-39.47%-101.89%84.11%-194.12%6.00%
Change in YoY Net Profit Growth (%)0.00%-33.04%103.37%-72.12%-68.06%-361.11%377.19%-62.41%186.00%-278.23%200.12%

Alchemist Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2009-2010 to 2019-2020.

Growth

Compounded Sales Growth
10 Years:-28%
5 Years:-47%
3 Years:-16%
TTM:-74%
Compounded Profit Growth
10 Years:%
5 Years:-12%
3 Years:-9%
TTM:-21246%
Stock Price CAGR
10 Years:-21%
5 Years:25%
3 Years:0%
1 Year:%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 4:03 pm

MonthMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Sep 2020
Equity Capital 12121213141414141414141414
Reserves 9410381781511227321-97-113-163-210-397
Borrowings 151157216342322789721738740752763768764
Other Liabilities 515585807923322222617817016116142
Total Liabilities 3083273945125661,1591,030999835822774733422
Fixed Assets 162173193200235276433405162154147140137
CWIP 404574135201202271900000
Investments 24242322222171169169169169
Other Assets 8285104176128679568574503500459424116
Total Assets 3083273945125661,1591,030999835822774733422

Below is a detailed analysis of the balance sheet data for Alchemist Ltd based on the most recent figures (Sep 2020) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2020, the value is ₹14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2020) which recorded ₹14.00 Cr..
  • For Reserves, as of Sep 2020, the value is ₹-397.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from ₹-210.00 Cr. (Mar 2020) to ₹-397.00 Cr., marking a decline of 187.00 Cr..
  • For Borrowings, as of Sep 2020, the value is ₹764.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from ₹768.00 Cr. (Mar 2020) to ₹764.00 Cr., marking a decrease of 4.00 Cr..
  • For Other Liabilities, as of Sep 2020, the value is ₹42.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹161.00 Cr. (Mar 2020) to ₹42.00 Cr., marking a decrease of 119.00 Cr..
  • For Total Liabilities, as of Sep 2020, the value is ₹422.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹733.00 Cr. (Mar 2020) to ₹422.00 Cr., marking a decrease of 311.00 Cr..
  • For Fixed Assets, as of Sep 2020, the value is ₹137.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹140.00 Cr. (Mar 2020) to ₹137.00 Cr., marking a decrease of 3.00 Cr..
  • For CWIP, as of Sep 2020, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2020) which recorded ₹0.00 Cr..
  • For Investments, as of Sep 2020, the value is ₹169.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2020) which recorded ₹169.00 Cr..
  • For Other Assets, as of Sep 2020, the value is ₹116.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹424.00 Cr. (Mar 2020) to ₹116.00 Cr., marking a decrease of 308.00 Cr..
  • For Total Assets, as of Sep 2020, the value is ₹422.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹733.00 Cr. (Mar 2020) to ₹422.00 Cr., marking a decrease of 311.00 Cr..

However, the Borrowings (764.00 Cr.) are higher than the Reserves (₹-397.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity +14231504-232-98-25-14-14-7-4
Cash from Investing Activity +-23-24-650-98-45-9-254-3-0
Cash from Financing Activity +5-151053427-6919111095
Net Cash Flow-4-210-40150-175-81-0-10

Free Cash Flow

MonthMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Free Cash Flow-119.00-125.00-181.00-308.00-281.00-756.00-747.00-771.00-769.00-762.00-816.00-819.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Debtor Days161615114994951,7327,0986,4715,8079,597
Inventory Days26323117111256230114361920
Days Payable17211042381768282,6412,5542,4304,894
Cash Conversion Cycle2527362512733751,1344,5723,9523,3974,723
Working Capital Days1416-9-07683711,2644,7914,4063,7585,867
ROCE %11%10%9%9%10%5%-3%-5%-5%-2%-9%-10%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020
Promoters34.94%34.94%34.94%34.94%34.94%34.94%34.94%34.94%34.94%34.94%34.94%34.94%
FIIs9.75%9.75%9.75%9.11%3.50%3.50%3.50%3.50%3.50%0.00%0.00%0.00%
DIIs3.00%2.48%2.48%2.48%2.49%2.49%2.49%2.49%2.49%2.48%2.48%1.51%
Government0.85%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public51.46%52.82%52.82%53.46%59.07%59.07%59.07%59.07%59.07%62.57%62.57%63.54%
No. of Shareholders8,6948,5918,5158,5098,7228,7088,5558,5718,6408,6409,31210,223

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 20Mar 19Mar 18Mar 17Mar 16
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -34.46-36.61-12.40-79.15-35.67
Diluted EPS (Rs.) -34.46-36.61-12.40-79.15-35.67
Cash EPS (Rs.) -29.56-31.52-6.75-73.28-19.90
Book Value[Excl.RevalReserv]/Share (Rs.) -144.68-110.27-73.55-61.3332.55
Book Value[Incl.RevalReserv]/Share (Rs.) -144.68-110.27-73.55-61.3332.55
Revenue From Operations / Share (Rs.) 10.6319.7219.6217.8277.47
PBDIT / Share (Rs.) -37.45-38.59-5.70-19.41-8.26
PBIT / Share (Rs.) -42.35-43.68-11.42-25.28-27.61
PBT / Share (Rs.) -42.76-44.69-12.16-80.00-38.02
Net Profit / Share (Rs.) -34.46-36.61-12.47-79.15-39.25
NP After MI And SOA / Share (Rs.) -34.46-36.61-12.47-79.15-35.67
PBDIT Margin (%) -352.38-195.73-29.03-108.90-10.66
PBIT Margin (%) -398.50-221.54-58.21-141.84-35.63
PBT Margin (%) -402.34-226.66-61.99-448.92-49.08
Net Profit Margin (%) -324.24-185.66-63.57-444.13-50.66
NP After MI And SOA Margin (%) -324.24-185.67-63.57-444.11-46.04
Return on Networth / Equity (%) 0.000.000.000.00-140.30
Return on Capital Employeed (%) -10.05-9.71-2.35-5.16-4.66
Return On Assets (%) -6.37-6.41-2.05-12.85-4.84
Long Term Debt / Equity (X) -3.89-5.05-7.46-8.8320.86
Total Debt / Equity (X) -3.91-5.07-7.50-8.8821.20
Asset Turnover Ratio (%) 0.010.030.030.020.01
Current Ratio (X) 2.432.662.932.852.82
Quick Ratio (X) 2.422.662.922.812.61
Inventory Turnover Ratio (X) 5.985.871.310.190.30
Interest Coverage Ratio (X) -91.90-38.22-4.50-11.66-2.23
Interest Coverage Ratio (Post Tax) (X) -83.56-35.26-9.27-14.68-7.79
Enterprise Value (Cr.) 765.56759.40757.00766.59762.63
EV / Net Operating Revenue (X) 53.1228.4028.4631.727.26
EV / EBITDA (X) -15.07-14.51-98.01-29.13-68.09
MarketCap / Net Operating Revenue (X) 0.090.090.411.300.25
Price / BV (X) -0.01-0.01-0.11-0.370.78
Price / Net Operating Revenue (X) 0.090.090.411.300.25
EarningsYield -35.90-19.07-1.53-3.42-1.78

After reviewing the key financial ratios for Alchemist Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 20, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 5. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
  • For Diluted EPS (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 5. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
  • For Cash EPS (Rs.), as of Mar 20, the value is -29.56. This value is below the healthy minimum of 3. It has increased from -31.52 (Mar 19) to -29.56, marking an increase of 1.96.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is -144.68. It has decreased from -110.27 (Mar 19) to -144.68, marking a decrease of 34.41.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is -144.68. It has decreased from -110.27 (Mar 19) to -144.68, marking a decrease of 34.41.
  • For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 10.63. It has decreased from 19.72 (Mar 19) to 10.63, marking a decrease of 9.09.
  • For PBDIT / Share (Rs.), as of Mar 20, the value is -37.45. This value is below the healthy minimum of 2. It has increased from -38.59 (Mar 19) to -37.45, marking an increase of 1.14.
  • For PBIT / Share (Rs.), as of Mar 20, the value is -42.35. This value is below the healthy minimum of 0. It has increased from -43.68 (Mar 19) to -42.35, marking an increase of 1.33.
  • For PBT / Share (Rs.), as of Mar 20, the value is -42.76. This value is below the healthy minimum of 0. It has increased from -44.69 (Mar 19) to -42.76, marking an increase of 1.93.
  • For Net Profit / Share (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 2. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
  • For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 2. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
  • For PBDIT Margin (%), as of Mar 20, the value is -352.38. This value is below the healthy minimum of 10. It has decreased from -195.73 (Mar 19) to -352.38, marking a decrease of 156.65.
  • For PBIT Margin (%), as of Mar 20, the value is -398.50. This value is below the healthy minimum of 10. It has decreased from -221.54 (Mar 19) to -398.50, marking a decrease of 176.96.
  • For PBT Margin (%), as of Mar 20, the value is -402.34. This value is below the healthy minimum of 10. It has decreased from -226.66 (Mar 19) to -402.34, marking a decrease of 175.68.
  • For Net Profit Margin (%), as of Mar 20, the value is -324.24. This value is below the healthy minimum of 5. It has decreased from -185.66 (Mar 19) to -324.24, marking a decrease of 138.58.
  • For NP After MI And SOA Margin (%), as of Mar 20, the value is -324.24. This value is below the healthy minimum of 8. It has decreased from -185.67 (Mar 19) to -324.24, marking a decrease of 138.57.
  • For Return on Networth / Equity (%), as of Mar 20, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 19) which recorded 0.00.
  • For Return on Capital Employeed (%), as of Mar 20, the value is -10.05. This value is below the healthy minimum of 10. It has decreased from -9.71 (Mar 19) to -10.05, marking a decrease of 0.34.
  • For Return On Assets (%), as of Mar 20, the value is -6.37. This value is below the healthy minimum of 5. It has increased from -6.41 (Mar 19) to -6.37, marking an increase of 0.04.
  • For Long Term Debt / Equity (X), as of Mar 20, the value is -3.89. This value is below the healthy minimum of 0.2. It has increased from -5.05 (Mar 19) to -3.89, marking an increase of 1.16.
  • For Total Debt / Equity (X), as of Mar 20, the value is -3.91. This value is within the healthy range. It has increased from -5.07 (Mar 19) to -3.91, marking an increase of 1.16.
  • For Asset Turnover Ratio (%), as of Mar 20, the value is 0.01. It has decreased from 0.03 (Mar 19) to 0.01, marking a decrease of 0.02.
  • For Current Ratio (X), as of Mar 20, the value is 2.43. This value is within the healthy range. It has decreased from 2.66 (Mar 19) to 2.43, marking a decrease of 0.23.
  • For Quick Ratio (X), as of Mar 20, the value is 2.42. This value exceeds the healthy maximum of 2. It has decreased from 2.66 (Mar 19) to 2.42, marking a decrease of 0.24.
  • For Inventory Turnover Ratio (X), as of Mar 20, the value is 5.98. This value is within the healthy range. It has increased from 5.87 (Mar 19) to 5.98, marking an increase of 0.11.
  • For Interest Coverage Ratio (X), as of Mar 20, the value is -91.90. This value is below the healthy minimum of 3. It has decreased from -38.22 (Mar 19) to -91.90, marking a decrease of 53.68.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is -83.56. This value is below the healthy minimum of 3. It has decreased from -35.26 (Mar 19) to -83.56, marking a decrease of 48.30.
  • For Enterprise Value (Cr.), as of Mar 20, the value is 765.56. It has increased from 759.40 (Mar 19) to 765.56, marking an increase of 6.16.
  • For EV / Net Operating Revenue (X), as of Mar 20, the value is 53.12. This value exceeds the healthy maximum of 3. It has increased from 28.40 (Mar 19) to 53.12, marking an increase of 24.72.
  • For EV / EBITDA (X), as of Mar 20, the value is -15.07. This value is below the healthy minimum of 5. It has decreased from -14.51 (Mar 19) to -15.07, marking a decrease of 0.56.
  • For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 0.09. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 19) which recorded 0.09.
  • For Price / BV (X), as of Mar 20, the value is -0.01. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 19) which recorded -0.01.
  • For Price / Net Operating Revenue (X), as of Mar 20, the value is 0.09. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 19) which recorded 0.09.
  • For EarningsYield, as of Mar 20, the value is -35.90. This value is below the healthy minimum of 5. It has decreased from -19.07 (Mar 19) to -35.90, marking a decrease of 16.83.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Alchemist Ltd as of March 12, 2025 is: ₹519.59

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Alchemist Ltd is Undervalued by 17,162.13% compared to the current share price 3.01

Default values used*: Default value of 15 for Stock P/E is used, Default value of 15% for ROE is used

Intrinsic Value of Alchemist Ltd as of March 12, 2025 is: 211.12

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Alchemist Ltd is Undervalued by 6,913.95% compared to the current share price 3.01

Default values used*: Default value of 15 for Stock P/E is used, Default value of 15% for ROE is used

Last 5 Year EPS CAGR: -59.37%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
    1. The stock has a low average ROCE of 1.67%, which may not be favorable.
    2. The stock has a high average Working Capital Days of 40.33, which may not be favorable.
    3. The stock has a high average Cash Conversion Cycle of 49.00, which may not be favorable.
    4. The company has higher borrowings (555.62) compared to reserves (-19.77), which may suggest financial risk.
    5. The company has not shown consistent growth in sales (209.69) and profit (-36.92).

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alchemist Ltd:
      1. Net Profit Margin: -324.24%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: -10.05% (Industry Average ROCE: 20.61%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 0% (Industry Average ROE: 61.74%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): -83.56
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 2.42
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 0 (Industry average Stock P/E: 131.82)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: -3.91
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    No data availabale for About the Company
    INDUSTRYADDRESSCONTACT
    Industry not foundAddress not foundContact not found
    Management Data not Available

    FAQ

    What is the latest intrinsic value of Alchemist Ltd?

    The latest intrinsic value of Alchemist Ltd as on 06 February 2025 is ₹519.59, which is 17162.13% higher than the current market price of ₹3.01, indicating the stock is undervalued by 17162.13%. The stock has a market capitalization of 4.08 Cr. and recorded a high/low of / during the current fiscal year 2024-2025. As of Sep 2020, the company has reserves of ₹-397 Cr and total liabilities of 422 Cr.

    What is the Market Cap of Alchemist Ltd?

    The Market Cap of Alchemist Ltd is 4.08 Cr..

    What is the current Stock Price of Alchemist Ltd as on 06 February 2025?

    The current stock price of Alchemist Ltd as on 06 February 2025 is 3.01.

    What is the High / Low of Alchemist Ltd stocks in FY 2024-2025?

    In FY 2024-2025, the High / Low of Alchemist Ltd stocks is /.

    What is the Stock P/E of Alchemist Ltd?

    The Stock P/E of Alchemist Ltd is .

    What is the Book Value of Alchemist Ltd?

    The Book Value of Alchemist Ltd is 283.

    What is the Dividend Yield of Alchemist Ltd?

    The Dividend Yield of Alchemist Ltd is 0.00 %.

    What is the ROCE of Alchemist Ltd?

    The ROCE of Alchemist Ltd is 9.70 %.

    What is the ROE of Alchemist Ltd?

    The ROE of Alchemist Ltd is %.

    What is the Face Value of Alchemist Ltd?

    The Face Value of Alchemist Ltd is 10.0.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Alchemist Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE